These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31440790)

  • 1. [Modern sonographic imaging of abdominal neuroendocrine tumors].
    Schwarze V; Marschner C; Grosu S; Rübenthaler J; Knösel T; Clevert DA
    Radiologe; 2019 Nov; 59(11):1002-1009. PubMed ID: 31440790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis.
    Westwood M; Joore M; Grutters J; Redekop K; Armstrong N; Lee K; Gloy V; Raatz H; Misso K; Severens J; Kleijnen J
    Health Technol Assess; 2013 Apr; 17(16):1-243. PubMed ID: 23611316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuroendocrine tumors of the pancreas].
    Juchems M; Kläsner B
    Radiologie (Heidelb); 2023 Dec; 63(12):894-899. PubMed ID: 37947864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-enhanced ultrasound can guide the therapeutic strategy by improving the detection of colorectal liver metastases.
    Sawatzki M; Güller U; Güsewell S; Husarik DB; Semela D; Brand S
    J Hepatol; 2021 Feb; 74(2):419-427. PubMed ID: 33065168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine tumors: characterization with contrast-enhanced ultrasonography.
    Dörffel Y; Wermke W
    Ultraschall Med; 2008 Oct; 29(5):506-14. PubMed ID: 19241507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of contrast-enhanced ultrasound to define prognosis and predict response to biotherapy in pancreatic neuroendocrine tumors.
    Del Prete M; Di Sarno A; Modica R; Lassandro F; Giorgio A; Bianco A; Muto M; Gasperi M; Del Prete F; Colao A; Montesarchio V; Faggiano A;
    J Endocrinol Invest; 2017 Dec; 40(12):1373-1380. PubMed ID: 28667452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous 68Ga-DOTATOC PET/MRI in patients with gastroenteropancreatic neuroendocrine tumors: initial results.
    Beiderwellen KJ; Poeppel TD; Hartung-Knemeyer V; Buchbender C; Kuehl H; Bockisch A; Lauenstein TC
    Invest Radiol; 2013 May; 48(5):273-9. PubMed ID: 23493121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuroendocrine tumors of the abdomen].
    Juchems M
    Radiologe; 2018 Jan; 58(1):36-44. PubMed ID: 29234821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-enhanced ultrasound: Improving the preoperative staging of hepatocellular carcinoma and guiding individual treatment.
    Zhang XY; Luo Y; Wen TF; Jiang L; Li C; Zhong XF; Zhang JY; Ling WW; Yan LN; Zeng Y; Wu H
    World J Gastroenterol; 2014 Sep; 20(35):12628-36. PubMed ID: 25253968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gastroenteropancreatic endocrine tumors].
    Schmid-Tannwald C; Schmid-Tannwald CM; Reiser MF; Berger F
    Radiologe; 2014 Oct; 54(10):989-97. PubMed ID: 25234769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New real-time image fusion technique for characterization of tumor vascularisation and tumor perfusion of liver tumors with contrast-enhanced ultrasound, spiral CT or MRI: first results.
    Jung EM; Schreyer AG; Schacherer D; Menzel C; Farkas S; Loss M; Feuerbach S; Zorger N; Fellner C
    Clin Hemorheol Microcirc; 2009; 43(1-2):57-69. PubMed ID: 19713601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Contrast-enhanced ultrasound (CEUS) of the liver : Critical evaluation of use in clinical routine diagnostics].
    Müller-Peltzer K; Rübenthaler J; Reiser M; Clevert DA
    Radiologe; 2017 May; 57(5):348-355. PubMed ID: 28255790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Imaging of neuroendocrine tumors of the gastrointestinal tract : Value of (hybrid) imaging diagnostics in radiology].
    Ebner R; Rübenthaler J; Ricke J; Sheikh GT; Unterrainer LM; Auernhammer CJ; Spitzweg C; Brendel M; Schmid-Tannwald C; Cyran CC
    Radiologie (Heidelb); 2024 Jul; 64(7):553-558. PubMed ID: 38713221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-enhanced ultrasound monitoring of perfusion changes in hepatic neuroendocrine metastases after systemic versus selective arterial 177Lu/90Y-DOTATOC and 213Bi-DOTATOC radiopeptide therapy.
    Giesel FL; Wulfert S; Zechmann CM; Haberkorn U; Kratochwil C; Flechsig P; Kuder T; Schwartz LH; Bruchertseifer F
    Exp Oncol; 2013 Jun; 35(2):122-6. PubMed ID: 23828389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [CEUS-Diagnostic of malignant liver lesions].
    Negrão de Figueiredo G; Müller-Peltzer K; Rübenthaler J; Clevert DA
    Radiologe; 2018 Jun; 58(6):528-537. PubMed ID: 29704013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastroenteropancreatic neuroendocrine tumors: multimodality imaging features with pathological correlation.
    Hayashi D; Tkacz JN; Hammond S; Devenney-Cakir BC; Zaim S; Bouzegaou N; Ounadjela S; Guermazi A
    Jpn J Radiol; 2011 Feb; 29(2):85-91. PubMed ID: 21359932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of neuroendocrine tumour metastases in the liver using contrast enhanced ultrasonography.
    Mörk H; Ignee A; Schuessler G; Ott M; Dietrich CF
    Scand J Gastroenterol; 2007 May; 42(5):652-62. PubMed ID: 17454888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin receptor scintigraphy in liver metastasis detection from gastroenteropancreatic neuroendocrine tumors.
    Schillaci O; Spanu A; Scopinaro F; Falchi A; Danieli R; Marongiu P; Pisu N; Madeddu G; Delle Fave G; Madeddu G
    J Nucl Med; 2003 Mar; 44(3):359-68. PubMed ID: 12621001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver metastases of neuroendocrine tumors: is it possible to diagnose different histologic subtypes depending on multiphasic CT features?
    Gulpinar B; Peker E; Kul M; Elhan AH; Haliloglu N
    Abdom Radiol (NY); 2019 Jun; 44(6):2147-2155. PubMed ID: 30863999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Qualitative and quantitative image analysis of CT and MR imaging in patients with neuroendocrine liver metastases in comparison to (68)Ga-DOTATOC PET.
    Flechsig P; Zechmann CM; Schreiweis J; Kratochwil C; Rath D; Schwartz LH; Schlemmer HP; Kauczor HU; Haberkorn U; Giesel FL
    Eur J Radiol; 2015 Aug; 84(8):1593-1600. PubMed ID: 25999064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.